Emmessar Biotech & Nutrition Ltd.

View in App
38.21 -0.68 ▼-1.8%

23 April 2024, 04:01:00 PM
Volume: 6,693

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ebnl.org
Market Cap 19.09 Cr.
Enterprise Value(EV) 13.59 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.15 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 33.14 Trailing Twelve Months Ending 2023-12
Industry PE 41.25 Trailing Twelve Months Ending 2023-12
Book Value / Share 14.10 Trailing Twelve Months Ending 2023-12
Price to Book Value 2.71 Calculated using Price: 38.21
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 0.50 Cr. 4,996,100 Shares
FaceValue 10
About Emmessar Biotech & Nutrition Ltd.
Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

Emmessar Biotech & Nutrition Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Emmessar Biotech & Nutrition Ltd. Performance

View details >>
1 Day
-1.75%
1 Week
+4.68%
1 Month
+26.82%
3 Month
+43.86%
6 Month
+52.96%
1 Year
+51.09%
2 Year
+16.32%
5 Year
+100.05%
10 Year
+946.85%

Emmessar Biotech & Nutrition Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -7.98 -40.75 78.73 36 16.42 19.4 29.1 8.01 7.85
Return on Capital Employed (%) -10.49 -59.37 79.46 31.46 9 18.87 45.29 15.71 14.99
Return on Assets (%) -5.08 -20.32 44.83 26.93 12.75 14.93 22.47 6.3 6.42

Emmessar Biotech & Nutrition Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 1 1 2 3 4 4 6 6 7 7
Non Curr. Liab. 0 1 1 0 0 0 0 1 1
Curr. Liab. 1 1 0 0 1 1 2 1 1 0
Minority Int.
Equity & Liab. 2 2 3 4 5 5 7 8 8 8
Non Curr. Assets 2 1 2 2 2 2 2 2 2 2
Curr. Assets 1 1 1 1 3 3 6 6 6 6
Misc. Exp. not W/O
Total Assets 2 2 3 4 5 5 7 8 8 8

Emmessar Biotech & Nutrition Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 2 2 3 1 1 3 7 0 1 1
Other Income 0 0 1 1 1 1 1 2 2 2
Total Income 2 2 4 3 2 5 8 2 3 3
Total Expenditure -2 -2 -2 -2 -1 -4 -6 -1 -2 -2
PBIDT 0 0 1 1 1 1 2 1 1 1
Interest 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 0 0 0
Exceptional Items -1 0 0
PAT 0 0 1 1 1 1 1 0 1 1
Adjusted EPS 0 -1 2 2 1 2 3 1 1 1

Emmessar Biotech & Nutrition Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 0 0 1 1 0 1 0 2 0
Cash Fr. Inv. 0 -1 -1 0 -1 0 -3 -1
Cash Fr. Finan.
Net Change 0 0 0 0 0 0 0 0 0
Cash & Cash Eqvt 0 0 0 0 0 0 1 0 0

Emmessar Biotech & Nutrition Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 58.51 58.19 56.31 58.53 59.08 58.19 59.53 59.53 59.53
Public 41.49 41.81 43.69 41.47 40.92 41.81 40.47 40.47 40.47
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Emmessar Biotech & Nutrition Ltd. Announcements

View details >>
Mon, 15 Apr 2024
Regulation 7(3) Certificate For Year Ended March 31 2024
Pls refer attachment
Fri, 12 Apr 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Pls refer attachment
Fri, 12 Apr 2024
For The Year Ended March 31 2024
Pls refer attachment

Emmessar Biotech & Nutrition Ltd. Technical Scans

View details >>
Mon, 22 Apr 2024
High Delivery Percentage High Delivery Percentage
High Increase in 1 Month High Increase in 1 Month
High Increase in 3 Months High Increase in 3 Months
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Emmessar Biotech & Nutrition Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 369,401.61 1,484.65 -3.6%
Cipla Ltd. 109,341.46 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. 100,341.19 5,952.10 -1.1%
Divi's Laboratories Ltd. 99,176.41 3,768.65 +0.8%
Zydus Lifesciences Ltd. 96,543.12 959.45 0.0%
Mankind Pharma Ltd. 93,651.57 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. 89,650.45 6,194.90 -0.7%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.48 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 29.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.19 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 71.71 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.46 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 54.22 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 113.58 6,194.90 -0.7%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.92 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-12 4.22 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.73 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-12 7.61 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.12 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-12 10.54 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.27 6,194.90 -0.7%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 0.02 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 12.85 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,194.90 -0.7%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,194.90 -0.7%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,484.65 -3.6%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,346.70 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,952.10 -1.1%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,768.65 +0.8%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 959.45 0.0%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,393.05 +2.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,194.90 -0.7%

Emmessar Biotech & Nutrition Ltd. FAQ's

What is Emmessar Biotech&Nut share price?
Can I buy Emmessar Biotech&Nut shares now?
What is the Market Cap of Emmessar Biotech&Nut?
What are the key metrics to analyse Emmessar Biotech&Nut?
What is the 52 Week High and Low of Emmessar Biotech&Nut?
What is the trend of Emmessar Biotech&Nut share price?